Background Evidence regarding the association between sarcopenia (skeletal muscle
depletion) and outcomes in patients with lung cancer varies across studies. We aimed to …

Purpose We aimed to explore whether sarcopenia diagnosed with the third lumbar vertebra
skeletal muscle index (L3 SMI) can be a predictor of prognosis for colorectal cancer (CRC) …

Background & aims The purpose of this meta-analysis was to summarize the published data
regarding associations between occurrence of severe treatment related toxicity and low …

Background/Aim: Sarcopenia describes the loss of skeletal muscle mass. While this
condition is associated with a high mortality in cancer patients, its influence on survival is still …

High interindividual variability (IIV) of the clinical response to epidermal growth factor
receptor (EGFR) inhibitors such as osimertinib in non-small-cell lung cancer (NSCLC) might …

Background Lung cancer is the leading cause of cancer-related mortality worldwide.
Sarcopenia, defined as the loss of muscle mass and function, is known to cause adverse …

Background This study aimed to investigate the association of computed tomography (CT)-
assessed sarcopenia and visceral adiposity with efficacy and prognosis of immune …

Background Sarcopenia and muscle tissue degradation are hallmarks of the majority of
chronic diseases, including non‐small cell lung cancer (NSCLC). A computed tomography …

Background Cisplatin-based chemotherapy is the first line of treatment for bladder cancer.
However, cisplatin induces muscle wasting associated with NF-κB and cancer cachexia …

Obesity, whose prevalence is pandemic and continuing to increase, is a major preventable
and modifiable risk factor for diabetes and cardiovascular diseases, as well as for cancer …